Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

takeda_usa_pharmaceuticals_u

Takeda sells four diabetes products to Teijin Pharma for $1.25m

February 26, 2021 Medical Communications Takeda

Takeda has entered into an agreement to transfer the assets, marketing rights, and, eventually, marketing authorisation associated with a portfolio …
News
top 10

Pharmafile.com’s top 10 news stories of the week

February 19, 2021 Medical Communications COVID-19, COVID-19 vaccine, Vaccine, pharma news, top 10, top news stories

In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …
News

New Cell Guidance technology has potential to help treat cancer

February 19, 2021 Medical Communications Cancer, cancer treatment, cell guidance systems, macrophages, pharma news

Cell Guidance Systems’ new POlyhedrin Delivery System (PODS) technology has been shown to have therapeutic potential in the treatment of …
News
cascade_chemistry_new_facility_rendering_highres

Cascade Chemistry begins $14m manufacturing facility expansion

February 19, 2021 Medical Communications Cascade Chemistry, manufacturing

Cascade Chemistry, a leading pharmaceutical contract development and manufacturing organisation, has initiated the $14 million construction of new facilities to …
News
cream-4713579_1920

Dermavant announces positive Phase III findings for psoriasis treatment tapinarof

February 19, 2021 Medical Communications Dermavant Sciences, psoriasis

Dermavant Sciences has announced positive safety and efficacy results from a planned interim analysis of PSOARING 3, a long-term, open-label …
News

RedHill enters manufacturing deal with Cosmo for two key products

February 19, 2021 Medical Communications RedHill Biopharma

RedHill Biopharma has announced agreements with Cosmo Pharmaceuticals to manufacture two of RedHill’s key products. Cosmo will manufacture Movantik, RedHill’s …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 12, 2021 Medical Communications

Over the past week, AstraZeneca’s COVID-19 jab has been at the centre of disputes about vaccine efficiency both in older …
News
opdivo_1_1

NICE recommends Bristol Myers Squibb’s skin cancer drug Opdivo for NHS use

February 12, 2021 Medical Communications Bristol-Myers Squibb, NICE, bristol myers squibb

NICE has issued final draft guidance recommending the routine use of Bristol Myers Squibb (BMS)’s Opdivo (nivolumab) as an option …
News
who_flag

AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances

February 12, 2021 Medical Communications AstraZeneca, COVID-19

Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …
News
ipos0_l

FDA approves Regeneron’s Evkeeza for HoFH

February 12, 2021 Medical Communications FDA, Regeneron

The FDA has approved Regeneron’s Evkeeza (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat …
News

Arthritis drug tocilizumab cuts COVID-19 deaths in hospital trial

February 12, 2021 Medical Communications COVID-19

The rheumatoid arthritis drug tocilizumab can reduce the risk of death in severe COVID-19 patients and shorten the time spent …
News
elizabeth_crain

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

February 10, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 5, 2021 Medical Communications COVID-19

In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …
News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021 Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …
News
pfizer_building_logo1

Pfizer withdraws application for emergency vaccine authorisation in India

February 5, 2021 Medical Communications COVID-19, Pfizer

Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026